Endogenous intoxication syndrome and system inflammatory reaction in choleperitonitis, complicated by abdominal sepsis


Cite item

Full Text

Abstract

Кубанский государственный медицинский университет Научно-исследовательский институт физико-химической медицины, г. Москва Институт молекулярных наук им. А.И.Виртанена Университет Восточной Финляндии, Куопио, Финляндия

About the authors

Кубанский государственный медицинский университет Научно-исследовательский институт физико-химической медицины, г. Москва Институт молекулярных наук им. А.И.Виртанена Университет Восточной Финляндии, Куопио, Финляндия

Author for correspondence.
Email: superego_ksmu@mail.ru
Кубанский государственный медицинский университет Научно-исследовательский институт физико-химической медицины, г. Москва Институт молекулярных наук им. А.И.Виртанена Университет Восточной Финляндии, Куопио, Финляндия Russian Federation

Email: author@vestnik-surgery.com
Боташев Алибек Амырбиевич – к.м.н., докторант кафедры оперативной хирургии и топографической анатомии Кубанского государственного медицинского университета Russian Federation

Email: yuriy.pomeshchik@mail.ru
Помещик Юрий Владимирович – к.м.н., научный сотрудник отдела нейробиологии Института мо- лекулярных наук им. А.И.Виртанена, Университет Восточной Финляндии Russian Federation

Email: superego_ksmu@mail.ru
Петросян Эдуард Арутюнович – д.м.н., проф., зав. кафедрой оперативной хирургии и топографиче- ской анатомии Кубанского государственного ме- дицинского университета Russian Federation

Email: vll@pochta.ru
Сергиенко Валерий Иванович – д.м.н., проф., ака- демик РАМН, директор научно-исследовательского института физико-химической медицины, г. Мо- сква Russian Federation

References

  1. Beliakov N.A., Miroshnichenko A.G., Malakhova M.Ia., Izotova O.G. Verifikatsiia endotoksikoza u bol'nykh s razlitym peritonitom.[Verification of endotoxicosis at patients with the poured peritonitis.]. Efferentnaia terapiia. 1995; 2: 14-19.
  2. Bogdanov S.N., Butkevich A.Ts., Vorob'ev Iu.A. Khirurgicheskoe lechenie iatrogennykh povrezhdenii zhelchnykh protokov pri laparoskopicheskoi kholetsistektomii.[Surgical treatment the yatrogennykh of damages of bilious channels at a laparoscopic holetsistektomiya.]. Annaly khirurgicheskoi gepatologii. 2008; 3: 109-110.
  3. Borisov A.E., Levin L.A., Kubachev K.G. Oslozhneniia laparoskopicheskoi kholetsistektomii.[Complications of a laparoscopic holetsistektomiya. ]. Endoskopicheskaia khirurgiia. 2001; 3: 34-40.
  4. Valyshev A.V. i dr. Rol' persistiruiushchei uslovno-patogennoi mikroflory kishechnika pri disbioze v vozniknovenii zabolevanii gepatobiliarnoi sistemy.[Role of persistiruyushchy uslovnopatogenny intestinal microflora at a disbioza in developing of diseases gepatobilyarno systems.]. Mikrobiologiia, epidemiologiia i immunobiologiia. 1997; 4: 87-88.
  5. Gallinger Iu.I., Karpenkova V.I. Laparoskopicheskaia kholetsistektomiia: opyt 3165 operatsii.[Laparoscopic holetsistektomiya: experience of 3165 operations.]. Endoskopicheskaia khirurgiia. 2007; 2: 3-7.
  6. Gal'perin E.I., Vetshev P.S. Rukovodstvo po khirurgii zhelchnykh putei.[Guide to surgery of bilious ways.]. M. 2006; 568.
  7. Galiamova S.V., Shirinskii V.G., Galiamov E.A. i dr. Oslozhneniia pri vypolnenii slozhnykh endokhirurgicheskikh vmeshatel'stv: sostoianie problemy.[Complications when performing difficult endosurgical interventions: condition of a problem.]. Endoskopicheskaia khirurgiia. 2008; 1: 25-29.
  8. Genok V.Ia. Endoskopicheskie tekhnologii – metod profilaktiki oslozhnenii.[Endoscopic technologies - a method of prophylaxis of complications.]. Endoskopicheskaia khirurgiia. 2008; 3: 13-15.
  9. Glukhov A.A., Koshelev P.I., Leibel's V.N. Lechenie «svezhikh» povrezhdenii vnepechenochnykh zhelchnykh protokov.[Treatment of fresh damages of extra hepatic bilious channels.]. Annaly khirurgicheskoi gepatologii. 2008; 3: 115-116.
  10. Kalinina N.M., Drygina L.B., Sokolian N.A. Autoimmunnaia patologiia endoteliia.[Autoimmune pathology endoteliya]. Meditsinskaia immunologiia. 2004; 1-2: 25-36.
  11. Kirsanova A.K. Mekhanizmy narusheniia funktsii endoteliia sosudov pri septicheskikh sostoianiiakh.[Malfunction mechanisms an endoteliya of vessels at septic states]. Anesteziologiia i reanimatologiia. 2003; 6: 72-75.
  12. Krakovskii M.E., Ashirmetov A.X. Osnovnye patogeneticheskie mekhanizmy narusheniia intoksikatsii razlichnogo geneza.[Main pathogenetic mechanisms of violation of intoxication of various genesis.]. Vestnik AMN SSSR. 1989; 12: 70-76.
  13. Kurbonov K.M., Daminova N.M. Diagnostika i taktika lecheniia posleoperatsionnogo zhelchnogo peritonita.[Diagnostics and tactics of treatment of postoperative bilious peritonitis]. Khirurgiia. 2007; 8: 38-42.
  14. Likhoded V.G., Iushchuk N.D., Iakovlev M.Iu. Rol' endotoksina gramotritsatel'nykh bakterii v infektsionnoi i neinfektsionnoi patologii.[Endotoxin role the gramotritsatelnykh of bacteria in infectious and noninfectious pathology.]. Arkhiv patologii. M. 1996; 2: 8-13.
  15. Salakhov I.M., Ipatov A.I., Konev Iu.V., Iakovlev M.Iu. Sovremennye aspekty patogeneza endotoksicheskogo shoka.[Modern aspects of pathogenesis of endotoxic shock.]. Uspekhi sovremennoi biologii. 1998; Vyp. 1: 33-50.
  16. Sergienko V.I., Petrosian E.A., Botashev A.A., Tereshchenko O.A. Rol' sistemnoi vospalitel'noi reaktsii i endotelial'noi disfunktsii v patogeneze zhelchnogo peritonita.[Role of system inflammatory reaction and endotelialny dysfunction in pathogenesis of bilious peritonitis.]. Vestnik Volgogradskogo gosudarstvennogo meditsinskogo universiteta. 2011; 2: 60-63.
  17. Sergienko V.I., Petrosian E.A., Botashev A.A., Tereshchenko O.A. Endotelial'naia disfunktsiia i metody ee korrektsii pri eksperimental'nom zhelchnom peritonite.[Endotelialny dysfunction and methods of her correction at experimental bilious peritonitis. ]. Khirurgiia. 2012; 3: 54-58.
  18. Skvortsova T.E. Kliniko-patogeneticheskie osobennosti diagnostiki i lecheniia zhelchnokamennoi bolezni u bol'nykh s narusheniiami dvigatel'noi funktsii i mikrobiotsenoza kishechnika.[Kliniko-patogenetichesky features of diagnostics and treatment of a zhelchekamenny disease at patients with violations of motive function and a microbiocenosis of intestines.]. Avtoref. dis. …. kand. med. nauk. SPb. 2007; 24.
  19. Freidlin I.S., Sheikin Iu.A. Endotelial'nye kletki v kachestve mishenei i produtsentov tsitokinov.[Endotelialny cages as targets and producers of tsitokin.]. Meditsinskaia immunologiia. 2001; 4: 499-514.
  20. Chereshnev V.A., Gusev E.Iu., Iurchenko L.I. Sistemnoe vospalenie mif ili real'nost'?.[System inflammation: myth or reality?]. Vestnik RAN. 2004; 3: 219-225.
  21. Shcherbakha N.A. Sostoianie fermentativnykh sistem miokarda v usloviiakh endogennoi intoksikatsii.[Condition of enzymatic systems of a myocardium in the conditions of an endogenous itoksikation. ]. Avtoref. dis. ... d-ra med. nauk. SPb. 1993; 44.
  22. Adams J.M., Hauser S.J., Adams S.A. Jr. et al. Entry of gut lymph into the circulation primes rat neutrophil respiratory burst in hemorrhagic shock. Crit. CareMed. 2001; 29: 11: 2194-2198.
  23. Aird W.C. The role of endothelium in severe sepsis and multiple organ dysfunction syndrome. Blood. 2003; 101: 10: 3765-3777.
  24. Asea A., Rehli M., Kabingu E. et al. Novel signal transduction pathway utilized by extracellular HSP70: role of tolllike receptor (TLR) 2 and TLR4. J. Biol. Chem. 2002; 277: 17: 15028-15034.
  25. Balkwill F. Cytokine amplification and inhibition on immune and inflammatory responses. J. Vira Hepatits. 1997; 4: 2: 6-15.
  26. Bhattacharyya J., Biswas S., Datta A.G. Non-extensive thermodynamics, heavy ion collisions and particle production at RHICenergies. Curr. Med. Chem. 2004; 11: 3: 359-368.
  27. Bhattacharyya S., Mandal D., Sen G.S. et al. Tumor-induced oxidative stress perturbs NFκB activity augmenting TNFα-mediated T cell death: protection by curcumin. Cancer Research. 2007: 67: 1: 362-370.
  28. Binotto M.A., Maeda N.Y., Lopes A.A. Evidence of endothelial dysfunction in patients with functionally univentricular physiology before completion of the Fontan operation. Cardiol. young. 2005; 15: 1: 26-30.
  29. Bone R.C. Modulators of coagulation. A critical appraisal of ther rolein sepsis. Arch. Intern. Med. 1992; 152: 7: 1381-1389.
  30. Bone R.C. Immunologic dissonance: a continuing evolution in our understanding of the systemic inflammatory response syndrome (SIRS) and the multiple organ dysfunction syndrome (MODS). Ann. Intern. Med. 1996; 125: 8: 680-687.
  31. Bottiger B.W., Motsch J., Braun V. et al. Marked activation of complement and leukocytes and an increase in the concentrations of soluble endothelial adhesion molecules during cardiopulmonary resuscitation and early reperfusion after cardiac arrest in humans. Critical Care Medicine. 2002; 30: 11: 2473-2480.
  32. Brown D.M., Hutchison L., Donaldson K. et al. The effect of oxidative stress on macrophages and lung epithelial cells: the role of phosphodiesterases 1 and 4. Toxicol. lett. 2007; 168: 1: 1-6.
  33. Bultinck J., Brouckaert P., Cauwels A. The in vivo contribution of hematopoietic cells to systemic TNF and IL-6 production during endotoxemia. Cytokine. 2006; 36: 3-4: 160-166.
  34. Cines D.B., Pollak E.S., Buck C.A. et al. Endothelial cells in physiology and in the pathophysiology of vascular disorders. Blood. 1998; 91: 10: 3527-3561.
  35. De Martin R., Hoeth M., Hofer-Warbinek R., Schmid J.A. The transcription factor NF-kappa B and the regulation of vascular cell function. Arterioscler. Thromb. Vasc. Biol. 2000; 20: 11: 883-888.
  36. Dichtl W., Dulak J., Frick M. et al. HMG-CoA reductase inhibitors regulate inflammatory transcription factors in human endothelial and vascular smooth muscle cells. Arterioscler. Thromb. Vasc. Biol. 2003; 23: 1: 58-63.
  37. Hack C.E., Zeerleder S. The endothelium in sepsis: source of and a target for inflammation. Crit. Care Med. 2001; 29: 7: 521-527.
  38. Hajjar K.A., Deora A. New concepts in fibrinolysis and angiogenesis. Curr. Atheroscler. Rep. 2000; 2: 5: 417-421.
  39. Hao W.L., Lee Y.K. Microflora of the gastrointestinal tract: a review. Methods Mol Biol. 2004; 268: 491-502.
  40. Harlan J.M., Winn R.K. Leukocyte-endothelial interactions: clinical trials of anti-adhesion therapy. Crit. Care Med. 2002; 30: 5: 5214-5219.
  41. Hiki N., Mimura Y., Ogawa T. et al. Pathophysiological relevance of the CD14 receptor in surgical patients: biological activity of endotoxin is regulated by the CD14 receptor. Innate Immunity. 2001; 7: 6: 461-466.
  43. Levi M., ten Cate H., Van der Poll T. Endothelium: interface between coagulation and inflammation. Crit. Care Med. 2002; 30: 5: 220-224.
  44. Mantovani A., Garlanda C., Introna M., Vecchi A. Regulation of endothelial cell function by proand anti-inflammatory cytokines. Transplant. Proc. 1998; 30: 8: 4239-4243.
  45. Meager A. Cytokine regulation of cellular adhesion mole cule expression in inflammation. Cytokine Growth Factor Rew. 1999; 10: 1: 27-39.
  46. Mercie P., Belloc F., Bihlou-Nabera S. et al. J. Lab. Clin. Med. 2000; 136: 402-411.
  47. Mukaiya M. et al. Isolated bacteria and susceptibilities to antimicrobial agents in biliary infections. Hepatogastroenterology. 2005; 52: 63: 686-690.
  48. Nieto N. Modulation of reactive oxygen species in endothelial cells by peroxynitritetreated lipoproteins. Hepatology. 2006; 44: 6: 1487- 1501.
  49. Niu J., Chang Z., Peng B. et al. Keratinocyte growth factor/fibroblast growth factor-7-regulated cell migration and invasion through activation of NF-kappaB transcription factors. J. Biol. Chem. 2007; 282: 9: 6001-6011.
  50. Paterson R.L., Webster N.R. Sepsis and the systemic inflammatory response syndrome. J. Roy. Coll. Surg. Edinb. 2000; 45: 6: 178-182.
  51. Peng H.B., Spiecker M., Liao J.K. Inducible nitric oxide: an autoregulatory feedback inhibitor of vascular inflammation. J. Immunol. 1998; 161: 4: 1970-1976.
  52. Pladzyk A., Reddy M., Yadav U.C. et al. Inhibition of Aldose Reductase Prevents Lipopolysaccharide-Induced Inflammatory Response in Human Lens Epithelial Cells Inves. Invest. Ophthalmol. Vis. Sci. 2006; 47: 12: 5395-5403.
  53. Reinhart K., Bayer O., Brunkhorst F., Meisner M. Markers of endothelial damage in organ dysfunction and sepsis. Crit. Care Med. 2002; 30: 5: 302-312.
  54. Saadane A., Masters S., Didonato J. et al. Parthenolide inhibits IkappaB kinase, NF-kappaB activation, and inflammatory response in cystic fibrosis cells and mice. Am. J. Respir.Cell. Mol. Biol. 2007; 36: 6: 728-736.
  55. Shan Y.X., Jin S.Z., Liu Y., Liu S.Z. Ionizing radiation stimulates secretion of proinflammatory cytokines: dose-response relationship, mechanisms and implications. Radiat. Environ. Biophys. 2006; 46: 1: 21-29.
  56. Sun H.V., Yokota H. Reduction of cytokine-induced expression and activity of MMP-1 and MMP-13 by mechanical strain in MH7A rheumatoid synovial cells. Matrix Biol. 2002; 21: 3: 263-270.
  57. Thomas X., Campos L., Mounier C. et al. Expression of heat-shock proteins is associated with major adverse prognostic factors in acute myeloid leukemia. Leuk. Res. 2005; 29: 9: 1049-1058.
  58. Topper J.N., Gimbrone M.A. Blood flow and vascular gene expression: fluid shear stress as a modulator of endothelial phenotype. Mol. Med. Today. 1999; 5: 1: 40-46.
  59. Tsujimoto H., Ono S., Majima T. et al. Differential toll-like receptor expression after ex vivo lipopolysaccharide exposure in patients with sepsis and following surgical stress. Clin. Immunol. 2006; 119: 2: 180-187.
  60. Van der Poll T., Buller H.T., Ten Cate H. et al. Activation of coagulation after administration of tumor necrosis factor to normal subjects. New Engl. J. Med. 1990; 322: 7: 1622-1627.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2012 ., ., ., ., .

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies